Table 2.

Dose taken by adults at withdrawal or last follow-up

	Carbamazepine	Gabapentin	Lamotrigine	Topiramate	Oxcarbazepine *
Inadequate seizure control	n=33	n=83	n=42	n=40	n=15
	991 (347); 400–1800	2414 (899); 300–4800	355 (175); 85–800	291 (168); 50–600	1480 (525); 300–2100
Unacceptable adverse events	n=50	n=35	n=30	n=68	n=29
	546 (189); 200–1000	1366 (636); 400–3000	178 (113); 25–550	137 (77); 25–400	895 (351); 300–2100
Inadequate seizure control and unacceptable adverse events	n=18	n=23	n=9	n=16	n=9
	711 (323); 200–1400	1878 (875); 600–3600	219 (178); 50–550	218 (110); 75–400	1150 (525); 450–1950
Other reason for withdrawal	n=13	n=14	n=19	n=14	n=7
	569 (317); 200–1200	1314 (466); 300–2100	184 (62); 50–300	189 (103); 75–500	814 (285); 600–1200
Remission of seizures	n=14	n=12	n=9	n=13	n=7
	614 (337); 200–1400	1475 (663); 300–2700	158 (92); 50–300	133 (57); 50–200	771 (293); 300–1200
Still on randomised drug	n=140	n=120	n=168	n=126	n=87
	662 (311); 100–2000	1496 (669); 300–3600	249 (136); 20–800	181 (108); 25–600	1019 (467); 300–2850

Data are mean (SD); range.

^*Figures in this column use data only for patients randomised after June 1, 2001.